Kevin R. Flaherty

Fernando J Martinez3
Fernando J. Martinez3
William D Travis2
Joseph P Lynch2
3Fernando J Martinez
3Fernando J. Martinez
Learn More
  • Fernando J Martinez, Sharon Safrin, Derek Weycker, Karen M Starko, Williamson Z Bradford, Talmadge E King +5 others
  • 2005
BACKGROUND Prospective data defining the clinical course in idiopathic pulmonary fibrosis (IPF) are sparse. OBJECTIVE To analyze the clinical course of patients with mild to moderate IPF. DESIGN Analysis of data from the placebo group of a randomized, controlled trial evaluating interferon-gamma1b. SETTING Academic and community medical centers. (More)
Idiopathic interstitial pneumonias are a diverse group of lung diseases with varied prognoses. We hypothesized that changes in physiologic and radiographic parameters would predict survival. We retrospectively examined 80 patients with usual interstitial pneumonia and 29 patients with nonspecific interstitial pneumonia. Baseline characteristics were(More)
A histologic feature of usual interstitial pneumonia is the presence of fibroblastic foci. As some patients with usual interstitial pneumonia and an underlying collagen vascular disease have a better prognosis, we hypothesized that they would have fewer fibroblastic foci. Pathologists reviewed surgical lung biopsies from 108 patients with usual interstitial(More)
  • Sameer R. Oak, Lynne Murray, Athula Herath, Matthew Sleeman, Ian Anderson, Amrita D. Joshi +6 others
  • 2011
BACKGROUND Idiopathic pulmonary fibrosis exhibits differential progression from the time of diagnosis but the molecular basis for varying progression rates is poorly understood. The aim of the present study was to ascertain whether differential miRNA expression might provide one explanation for rapidly versus slowly progressing forms of IPF. METHODOLOGY(More)
The participating COMET investigators are listed in the acknowledgments Idiopathic pulmonary fibrosis (IPF) is characterized by progressive deposition of extracellular matrix, worsening dyspnea, and eventual mortality. Pathogenesis of IPF is poorly understood and the role inflammation and activated leukocytes play in the disease process is controversial.(More)
RATIONALE Biomarkers in easily accessible compartments like peripheral blood that can predict disease progression in idiopathic pulmonary fibrosis (IPF) would be clinically useful regarding clinical trial participation or treatment decisions for patients. In this study, we used unbiased proteomics to identify relevant disease progression biomarkers in IPF.(More)
  • 1